NCT04816396 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Amieva H, Robert PH, Grandoulier AS, Meillon C, De Rotrou J, Andrieu S, Berr C, Desgranges B, Dubois B, Girtanner C, Joël ME, Lavallart B, Nourhashemi F, Pasquier F, Rainfray M, Touchon J, Chêne G, Dartigues JF
Group and individual cognitive therapies in
Rogers C, Keller C
Roy's adaptation model to promote physical activity among sedentary older adults. Geriatr Nurs. 2009 Mar-Apr;30(2 Suppl):21-6. doi: 10.1016/j.gerinurse.2009.02.002.
Roy C, Whetsell MV, Frederickson K
The Roy adaptation model and research. Nurs Sci Q. 2009 Jul;22(3):209-11.
Wagner C, van der Wal G, Groenewegen PP, de Bakker DH
The effectiveness of quality systems in nursing homes: a review. Qual Health Care. 2001 Dec;10(4):211-7. Review.
Wu LF
Group integrative reminiscence therapy on self-esteem, life satisfaction and depressive symptoms in institutionalised older veterans. J Clin Nurs. 2011 Aug;20(15-16):2195-203. doi: 10.1111/j.1365-2702.2011.03699.x. Epub 2011 Jun 1.

The Effects of the Instrumental Reminiscence Therapy Based on Roy's Adaptation Model on Adaptation, Life Satisfaction and Happiness in Older Adults: A Randomized-controlled Trial

Details for clinical trial NCT04816396

Clinical trial NCT04816396 - References